分享至:  http://ieknet.iek.org.tw  http://ieknet.iek.org.tw  http://ieknet.iek.org.tw 
 
關於 IEKView
| About IEKView

由工研院產科國際所身為我國指標性智庫,以兼具專業性與權威性之IEK觀點(Insightful、Enlightening、Knockout、Visionary,簡稱IEKView),為客戶創造整合性附加價值及提升產業效能,同時推動政府與產業鏈建立共識,成功複製台灣經驗向海外輸出,提升台灣產業競爭力共盡心力
 
最新 IEKView
| Latest IEKView

IEKView:Toward Precision Medicine; A Niche for Taiwanese Players 2018/12/26
   
  Since the phrase “precision medicine” was mentioned in 2011 by the United States National Research Council (NRC) in its report "Toward Precision Medicine”, the US, UK, China, France, and Korea have directed significant investments in research and infrastructure related to precision medicine. In July 2017, the Food and Drug Administration (FDA) approved the first companion diagnostic product centered on Next Generation Sequencing (NGS), marking the beginning of the precision medicine era with gene sequencing results being used as the basis of medication decisions. The modern medical system administers treatments based on symptom descriptions and the findings of routine examinations. This approach can deal with most illnesses but has been ineffective in terms of early diagnostics, precise treatment and risk control for genetic diseases, cancers, communicable and chronic diseases.
 
 
IEKView 集錦
| IEKView Collection
 
資料查詢中,請稍待...
IEK產業情報網首頁關於我們服務介紹客服信箱
版權所有©工業技術研究院 產業科技國際策略發展所
APP store googleplay